Senores Pharmaceuticals Limited (BOM:544319)

Market Cap	25.67B
Revenue (ttm)	3.98B
Net Income (ttm)	585.60M
Shares Out	n/a
EPS (ttm)	16.12
PE Ratio	43.83
Forward PE	20.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,879
Average Volume	18,559
Open	557.00
Previous Close	556.90
Day's Range	543.80 - 564.40
52-Week Range	440.00 - 664.00
Beta	n/a
RSI	64.73
Earnings Date	Jul 23, 2025

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line. It also exports its products. The company provides consulting and licensing services. Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 113
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544319

Financial Performance

In 2024, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.64% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.17%.